- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02898935
Improvement of the Accuracy of Spatial Representation of Invasive Exploratory Electrodes in Focal Epilepsy (ELEC3D)
Reconstruction software allows visualization of cortical structure in 3 dimensions, showing on a single picture the position of all the electrodes. The EEG signal of each recording plot of the electrode is analyzed and compared with the underlying brain structure reconstructed by the software. It is therefore possible to visualize 1) ictogenic and epileptogenic areas using neurophysiological stereoelectroencephalography (SEEG) data and 2) adjacent functional cortical areas with functional imaging and SEEG. Software makes it possible to determine the links between these areas. This study aims to show that using these software is an asset in surgical decision and in the choice of surgical strategy.
Each patient has presurgical evaluation (usual care), including morphologic and (if necessary) functional MRI, EEG and SEEG. In this study, software will be used to analyze the processed data (FSL software, FMRIB laboratory, Oxford University and BrainVisa/Anatomist. The surgical decision will be taken according to the usual staff procedures, based on the usual examination results. After the decision making process, the staff will be asked to reconsider the surgical decision, according to the analysis provided by the software. The discrepancies between the decisions will be recorded.
Study Overview
Status
Conditions
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Paris, France, 75019
- Fondation Ophtalmologique A. De Rothschild
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- children aged 18 months to 17 years old
- drug resistant focal epilepsy
- scheduled for deep brain electrodes exploration to assess surgical indication
Exclusion Criteria:
- contraindication to anesthesia or surgery
- refusal (of parents or child) to participate in the study
- no health insurance coverage
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
number of patients for whom surgical strategy would change if using the software
Time Frame: 1 day
|
change in medical strategy includes surgery indication, resection volume, topography of resection area
|
1 day
|
Collaborators and Investigators
Investigators
- Principal Investigator: Mathilde CHIPAUX, MD, Fondation OPH A de Rothschild
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- MCX_2015_32
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Focal Epilepsy
-
Assistance Publique - Hôpitaux de ParisMedtronicRecruitingEpilepsy | Focal Epilepsy | Drug Resistant | Drug-resistant Focal Epilepsy | Epilepsies, FocalFrance
-
Great Ormond Street Hospital for Children NHS Foundation...Active, not recruitingEpilepsies, Partial | Intractable Epilepsy | Focal Epilepsy | Refractory Epilepsy | Epilepsy Intractable | Epilepsy in Children | Epilepsy, FocalUnited Kingdom
-
Peking Union Medical College HospitalGuidon Pharmaceutics Ltd.RecruitingRefractory Focal EpilepsyChina
-
Rapport Therapeutics Inc.RecruitingEpilepsy | Focal Epilepsy | Focal Onset Seizure | Seizure | Refractory Focal Epilepsy | Focal SeizureUnited States
-
Neuroelectrics CorporationCompletedEpilepsy | Seizures | Refractory Epilepsy | Epilepsy, Tonic-Clonic | Epilepsy in Children | Seizures, Focal | Focal SeizureSpain, United States, France, Belgium
-
Fondation Ophtalmologique Adolphe de RothschildRecruitingDrug Resistant Epilepsy | Pediatrics | Epilepsies, FocalFrance
-
BiocodexCompletedPharmacoresistant Focal EpilepsiesFrance
-
UCB Biopharma SRLTerminatedAn Open-label Extension Study of UCB0942 in Adult Patients With Highly Drug-resistant Focal EpilepsyHighly Drug-resistant Focal EpilepsyBelgium, Bulgaria, Germany, Hungary, Netherlands, Spain
-
UCB Biopharma S.P.R.L.PRA Health SciencesCompletedHighly Drug-resistant Focal EpilepsyBelgium, Bulgaria, Germany, Hungary, Netherlands, Spain
-
BiogenCompletedEpilepsy, Focal Seizures, Partial SeizuresUnited States